Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
13.92 MEUR
108.35 MEUR
255.39 M
Om SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.LTD
Sektor
Bransch
Huvudkvarter
Shanghai
Webbplats
Employees (FY)
948
Grundat
1996
ISIN
CNE1000000W4
FIGI
BBG000L4ZV82
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
